10-K: Chicago Atlantic Reports Full Year 2024 Results, Portfolio Yields 17.2%

Sentiment:

Annual Report (Form 10-K)


Chicago Atlantic reports its financial results for the year ended December 31, 2024, highlighting a portfolio yield to maturity of 17.2% and strategic portfolio management.

Capital raiseThe company may seek to raise further equity capital and issue debt securities in order to fund its future investments in loans.The company has a Shelf Registration Statement on Form S-3, allowing it to sell up to $500 million of its securities.
Worse than expectedInterest income decreased by approximately $0.8 million for the year ended December 31, 2024 compared to the year ended December 31, 2023.Incentive fees decreased approximately $0.8 million primarily attributable to the year over year decrease in Core Earnings, as defined in the Management Agreement, of $2.4 million, the base on which the incentive fees are earned.

Summary

  • Chicago Atlantic Real Estate Finance, Inc. is a commercial mortgage REIT focused on providing attractive, risk-adjusted returns to stockholders.
  • The company primarily invests in senior loans to state-licensed cannabis operators, secured by real estate and other assets.
  • As of December 31, 2024, the loan portfolio totaled approximately $410.2 million, with a weighted-average yield-to-maturity internal rate of return (YTM IRR) of 17.2%.
  • The company's loans are secured by real estate and other assets, with 36.5% backed by personal or corporate guarantees.
  • The management agreement with Chicago Atlantic REIT Manager, LLC was automatically renewed on April 30, 2024.
  • The company is in compliance with all financial covenants with respect to the Revolving Loan and the Unsecured Notes as of December 31, 2024.
  • The company has elected to be taxed as a REIT, which generally eliminates corporate-level income tax on distributed income.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While the company highlights positive aspects like portfolio yield and strategic management, it also acknowledges risks associated with the cannabis industry, external management, and regulatory uncertainties. The decrease in interest income and incentive fees is a negative factor.

Positives

  • The company's portfolio investments have attractive risk-adjusted returns.
  • The company has a disciplined, credit-first underwriting process.
  • The company has nimble execution capabilities.
  • The company has a diversified financing sources with increased access to equity and debt capital.
  • The company is in compliance with all financial covenants with respect to the Revolving Loan and the Unsecured Notes as of December 31, 2024.

Negatives

  • The company has limited operating history.
  • The company operates in a competitive market for the origination and acquisition of attractive lending opportunities.
  • The company is externally managed by its Manager and its growth and success depends on its Manager, its key personnel and investment professionals.
  • The company provides loans to established companies operating in the cannabis industry, which involves significant risks.
  • The company's growth depends on external sources of capital, which may not be available on favorable terms or at all.
  • Interest rate fluctuations could increase the company's financing costs.
  • There are various conflicts of interest in the company's relationship with its Manager.
  • Failure to maintain the company's qualification as a REIT for U.S. federal income tax purposes would cause the company to be taxed as a regular corporation.
  • The company may in the future pay distributions from sources other than its cash flow from operations.

Risks

  • Strict enforcement of federal laws regarding cannabis would likely result in the company's inability to execute its business plan.
  • New laws that are adverse to the company's borrowers may be enacted at the federal or state level.
  • The company will not own real estate as long as it is used in cannabis-related operations due to current statutory prohibitions and exchange listing standards.
  • The company may have difficulty accessing the service of banks and other financial institutions.
  • The company may incur significant debt, and its governing documents contain no limit on the amount of debt it may incur.
  • The value of the company's common stock may be volatile and could decline substantially.
  • The company may not be able to obtain or maintain required licenses and authorizations to conduct its business.
  • Uncertainty and adverse changes in macroeconomic conditions of markets in which the company participates and increased costs of energy, labor, construction materials and other factors could have an adverse impact on the company's financial performance and results of operations.

Future Outlook

The company intends to grow the size of its portfolio by continuing to make loans to leading operators and property owners in the cannabis industry and may modify or expand its growth strategy from time to time.

Industry Context

The company operates in the competitive market of lending to the cannabis industry, where access to traditional financing is limited due to federal regulations. The company differentiates itself by targeting lower-risk operators and facilities.

Comparison to Industry Standards

  • The document does not provide specific comparisons to industry standards or comparable companies.
  • However, it highlights the company's focus on lower-risk characteristics compared to competitors, such as limiting exposure to ground-up construction and lending to profitable facilities.
  • The document mentions that certain competitors with typical equity REIT land ownership models often have long-term leases averaging 10 years or more, while the company's loans have a weighted average maturity of 2.2 years.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Co-Chief Executive OfficerAnthony CappellPeter SackMarch 7, 2024Appointment of Peter Sack as Co-Chief Executive Officer
PresidentN/AAndreas BodmeierMarch 7, 2024Appointment of Andreas Bodmeier as President
Chief Financial OfficerInterimPhillip SilvermanMarch 7, 2024Appointment of Phillip Silverman as Chief Financial Officer
Member of the BoardDonald GulbrandsenN/AJanuary 1, 2025Resignation
Non-independent member of the BoardAndreas BodmeierN/AJanuary 1, 2025Resignation to ensure Board remains majority independent

Legal Proceedings

  • The Company is not currently subject to any material legal proceedings, nor, to our knowledge, is any material legal proceeding threatened against us.

Related Party Transactions

  • The company has a management agreement with Chicago Atlantic REIT Manager, LLC, which is entitled to base management fees and incentive compensation.
  • The company may co-invest with other investment vehicles managed by its affiliates.
  • The company may invest in, acquire, sell assets to or provide financing to investment vehicles managed by its Manager or affiliates of its Manager and their borrowers or purchase assets from, sell assets to, or arrange financing from any such investment vehicles and their borrowers.
  • In December 2024, John Mazarakis, who serves as our Executive Chairman of the Board, was appointed to serve as Chief Executive Officer and Co-Executive Chairman of the Board of Vireo Growth Inc. (Vireo) which is one of our portfolio companies and a related party.
  • During the quarter ended December 31, 2024, the Company originated a loan to a subsidiary of Vireo, collateralized by real estate assets in Minnesota.

Stakeholder Impact

  • The company's performance directly impacts its stockholders through dividends and capital appreciation.
  • The company's lending activities support state-licensed cannabis operators, contributing to the growth of the cannabis industry.
  • The company's operations are subject to regulations that impact its ability to operate and provide returns to stakeholders.

Next Steps

  • The company intends to continue providing financing to state-licensed cannabis cultivators, processors, distributors, retailers, vertically-integrated cannabis firms, non-plant touching manufacturers, suppliers, and service providers to such industries, and other businesses ancillary thereto, located in the U.S. and Canada.
  • The company will continue to focus on operators with strong collateral, in the form of real estate, equipment and receivables owned by the borrower, and may opportunistically invest in all asset lien cash flow loans, to the extent that allows us to maintain our qualification as a REIT, with a strict focus on adhering to conservative underwriting criteria.

Key Dates

DateDescription
March 30, 2021Company formed
May 1, 2021Management Agreement effective date
December 31, 2021Elected to be taxed as a REIT
January 19, 2023Shelf Registration Statement on Form S-3 became effective
February 15, 2023Completed a registered direct offering of common stock
June 20, 2023Entered into an At-the-Market Sales Agreement
April 30, 2024Management Agreement automatically renewed
October 18, 2024Entered into a Loan Agreement for $50.0 million in senior unsecured notes
December 11, 2024Mr. Donald Gulbrandsen, notified the Board of his resignation effective as of January 1, 2025
December 27, 2024Dr. Andreas Bodmeier, notified the Board of his resignation effective as of January 1, 2025
March 7, 2025Closing price of common stock was $16.15 per share

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.